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Transcription factor profiling in individual
hematopoietic progenitors by digital RT-PCR
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Contributed by Irving L. Weissman, September 26, 2006 (sent for review July 2, 2006)
We report here a systematic, quantitative population analysis of
transcription factor expression within developmental progenitors,
made possible by a microfluidic chip-based ‘‘digital RT-PCR’’ assay
that can count template molecules in cDNA samples prepared from
single cells. In a survey encompassing five classes of early hema-
topoietic precursor, we found markedly heterogeneous expression
of the transcription factor PU.1 in hematopoietic stem cells and
divergent patterns of PU.1 expression within flk2 and flk2
common myeloid progenitors. The survey also revealed significant
differences in the level of the housekeeping transcript GAPDH
across the surveyed populations, which demonstrates caveats of
normalizing expression data to endogenous controls and under-
scores the need to put gene measurement on an absolute, copy-
per-cell basis.
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S tem cells gives rise to terminally differentiated cells of diversetypes through a stepwise process involving the production of
intermediates of progressively restricted lineage potential. This
unfolding program is controlled by a transcriptional regulatory
network: a chemical state machine with sequencing logic imple-
mented by cross-regulating transcription factors, the states of the
network realized in the abundance profile of these regulatory
molecules. Transitions between preferred states are brought on by
intrinsic metastability, stochastic fluctuation, and external signals
(1–3). Understanding the behavior of these networks is the key to
understanding development itself. A prerequisite is the ability to
characterize network states quantitatively, but the sensitivity of
current gene profiling methods is not fully adequate to this task.
Here we report on a study of hematopoietic stem cells (HSCs) and
other early blood progenitors using an assay that overcomes the
sensitivity problem.
Conventional gene expression assays typically require thou-
sands of cells’ worth of RNA as analyte. Developmentally
interesting cells, especially stem cells, are not always easily
isolated in such quantities. More fundamentally, population-
average expression data provide an incomplete picture, because
functionally significant variations in regulatory-network state
undoubtedly exist in cell types defined on the basis of a few
phenotypic criteria. One consequence of this is that population-
averaged experiments are subject to systematic errors in inter-
pretation: although one can reliably infer qualitative trends from
their results, it is difficult if not impossible to generate precise,
quantitative results. Modern theories of systems biology are able
to make quantitative predictions, and to test these theories
quantitative data are required. Flow cytometry has transformed
the study of cellular differentiation by revealing diversity in the
patterns of surface protein expression within populations of
superficially similar cells. Similarly, one would like to survey
transcriptional network states within populations cross-
sectionally, which is possible only by measuring gene expression
in individual cells.
In principle, RT-PCR has the sensitivity required for single-
cell gene-expression analysis. However, the quantitation of rare
messages, such as those for transcriptional regulators, pushes the
limits of the art. Published single-cell protocols tend to be
elaborate in terms of assay validation and practice (4). To
address this problem, we have developed a highly sensitive
quantitative RT-PCR assay based on standard 5-nuclease probe
(TaqMan) chemistry and primer–probe design rules. The
method uses a commercially available microfluidic chip to
partition individual cDNA molecules into discrete reaction
chambers before PCR amplification (Fig. 1). In effect, the chip
performs a massively parallel limiting-dilution assay, a form of
‘‘digital PCR’’ (5). In conventional quantitative PCR, quantita-
tion is based on the number of amplification cycles required for
dye fluorescence to reach a given threshold. Slight variations in
amplification efficiency between reactions are magnified be-
cause of the exponential character of PCR; for this reason,
interassay comparisons are only valid if gene-of-interest mea-
surements are normalized to measurements on endogenous
controls or synthetic standards (6). In digital PCR, quantitation
relies on binary, positivenegative calls for each subreaction
within the partitioned analyte, affording an absolute readout of
DNA copy number with single-molecule resolution. Applying
the chip assay to cDNA generated from synthetic RNA stan-
dards, we have demonstrated that the sensitivity and linearity of
quantitation is sufficient to address transcript measurements on
single cells (see Materials and Methods).
We applied the digital assay to a single-cell gene expression
survey focused on the early steps of hematopoiesis. After staining
with fluorescent antibodies, flow cytometry can be used to frac-
tionate blood progenitors based on membrane-protein expression.
The lineage potential of many different subsets has been investi-
gated by using clonal assays, resulting in schema for the prospective
isolation of progenitors based on surface antigen profiles. Immu-
nophenotyped cells are readily sorted into individual tubes for
single-cell analysis (7). In our experiments, cells were sorted directly
into RT-PCR buffer; we subsequently added primers for the genes
of interest, reverse-transcribed the RNA, and quantitated the
cDNA in the digital PCR chip (Fig. 2). The study encompassed
murine blood progenitors belonging to the following canonical
populations: HSCs, common lymphoid progenitors (CLPs), com-
mon myeloid progenitors (CMPs), and megakaryocyte–erythroid
progenitors (MEPs) (8–13). (Fig. 5, which is published as support-
ing information on the PNAS web site, positions these cell types
within the classical model of the hematopoietic lineage tree.) Some
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recent work argues that the CMP subset is heterogeneous, func-
tional diversity being correlated with differential expression of the
cytokine receptor flk2 (14, 15). We therefore decided to look at
flk2 and flk2 CMP subsets, to see whether their gene expression
profiles were different. Our survey includes data from 116 individ-
ual cells, about two dozen from each of the five cell types of interest
(HSC, CLP, CMPflk2, CMPflk2, and MEP).
We measured the levels of two transcripts within every cell: a
transcription factor, PU.1, and a housekeeping gene, GAPDH.
PU.1 is known to be a major regulator of hematopoiesis. Its best
understood role is the promotion of granulocyte–macrophage fate:
expressed at high levels, PU.1 activates granulocyte–macrophage
differentiation gene batteries, and PU.1 up-regulation seems to be
instrumental in funneling CMPs toward the granulocyte–
macrophage progenitor (GMP) lineage (16, 17). PU.1 is also
thought to play other, context-dependent roles in blood differen-
tiation at intermediate levels of expression (18, 19). GAPDH
encodes a glycolytic enzyme, glyceraldehyde-3-phosphate dehydro-
genase. This gene commonly serves as an endogenous control in
quantitative RT-PCR assays. In this practice, the readout for every
gene of interest is normalized to the GAPDH signal, on the
idealized assumption that GAPDH expression is uniform across
cell types. Our assay reports absolute transcript levels, in copies per
cell, so we did not need a reference for PU.1 quantification.
However, we were interested in finding out to what extent GAPDH
expression is truly independent of cell type. In addition, we ex-
pected levels of PU.1 to be so low that Poisson noise might obscure
any clues our analysis would give to the general character of
expression distributions. GAPDH is a high-abundance transcript,
so we anticipated that its expression would be more informative in
this regard.
Results and Discussion
We carried out on-chip assays using RNA runoff template to
measure the efficiency and reproducibility of the digital RT-
PCR assay. The estimated RNA-to-cDNA conversion efficiency
was 0.50  0.10 for PU.1 (CV  20%) and 0.29  0.09 for
GAPDH (CV  29%). We found an interassay CV of 10% in
similar trials using DNA standards, so some of the variability
in the efficiency estimates came from the chip itself. Variation
Fig. 1. The Digital Array chip. (a) A PCR end-point scan of a chip. In this
false-color image, the FAM signal (GAPDH) is shown in green and the Cy5
signal (PU.1) is shown in red. The 12 samples analyzed here correspond to
cDNA preparations derived from individual HSCs. Within a sample panel, 7.5
l of analyte is partitioned into 1,200 isolated reaction chambers (‘‘wells’’)
before PCR. At the cDNA concentrations encountered in the single-cell survey,
almost all wells capture either zero or one template molecules; after PCR, the
count of high-intensity wells provides a readout of the number of template
molecules in the original, unamplified sample. (b) Histogram of well intensi-
ties within a single Digital Array panel after 40 cycles of PCR. The analyte was
cDNA reverse-transcribed from PU.1 runoff transcript. Positivenegative calls
are based on an operator-defined threshold. (c) Digital PCR response charac-
teristic. In the digital assay, positive reactions signal compartments capturing
one or more template molecules at the start of the PCR. At high template
concentrations, a significant fraction of compartments start out with multiple
template copies and the response curve becomes increasingly nonlinear. For
a panel with n compartments, the number of input molecules, x, can be
computed from the readout of positive compartments, y, by using the equa-
tion x  log(1  yn)log(1  1n) (Supporting Text).
Fig. 2. Experimental procedure used in the single-cell survey. (a) Cells are
harvested from mouse bone marrow, then enriched for c-kit early progeni-
tors by immunomagnetic separation. (b) Purified cells are stained with a panel
of fluorescent antibodies to surface proteins whose expression patterns de-
fine progenitor types of interest. (c) FACS is used to dispense individual
immunophenotyped cells into RT-PCR buffer, where they undergo hypotonic
detergent lysis, releasing their mRNA. (d) Gene-specific primers and probes,
reverse transcriptase, and DNA polymerase are added to the lysates, and the
samples are reverse-transcribed in a standard thermocycler. (e) Completed
reactions are loaded into the digital PCR chip, which is pneumatically parti-
tioned and thermocycled on a flat block. ( f) End-point fluorescence images of
the chip are processed to read out the levels of the transcripts targeted by the
TaqMan assays.
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in the loaded sample volume probably accounts for most of the
chip-related technical noise. The limiting factor in the precision
of the digital RT-PCR method is likely to remain the technical
variability of reverse transcription (20).
The results of the single-cell survey are summarized in Fig. 3.
All cell types gave mean readouts for GAPDH and PU.1
substantially exceeding the background of false positive signals
detected in No Template and No RT control panels (Table 2,
which is published as supporting information on the PNAS web
site).
PU.1 expression is highly elevated in the CMPf lk2 subset,
and strongly down-regulated in the MEPs (Table 3, which is
published as supporting information on the PNAS web site). The
other three subsets show intermediate levels of expression, but
the CMPf lk2 resembles the MEP, with a less pronounced
downshift. We used the Kolmogorov–Smirnov (K-S) test to
measure the resemblance between the PU.1 data sets (Table 4,
which is published as supporting information on the PNAS web
site). The HSC distribution bears a strong resemblance to the
distributions in the CLP and CMPf lk2 cell types. The CMP
f lk2 stands alone: the P value for similarity was 0.01 in every
comparison involving this set.
A previous, nonquantitative single-cell study of blood progen-
itors found that HSCs display variegated expression of tran-
scripts normally associated with downstream lineages, including
PU.1 (21). This could represent nonproductive, ‘‘leaky’’ tran-
scription, if the loci for downstream lineages are kept in a default,
open chromatin state until fate commitment (22). Alternatively,
‘‘noisy’’ transcription might be a mechanism for symmetry
breaking, priming daughter cells toward diverse fates when the
stem cell starts to proliferate and differentiate (23). The dis-
tinction between leaky or noisy transcription and regulated
transcription may be hard to draw; our data suggests that wide
variations in message abundance between individual cells are the
rule rather than the exception. However, the K-S comparison
results and the relatively broad profile of the PU.1 distribution
in the HSC subset argue that PU.1 expression is either loosely
regulated or heterogeneously regulated within the stem cell
compartment.
A keystone of the classical model of hematopoietic differen-
tiation is the division of progenitors into two major populations
downstream of the multipotent progenitor (MPP): the lym-
phoid-restricted CLP, which gives rise to pro-B and pro-T cells,
and the myeloerythroid-restricted CMP, which gives rise to
granulocyte–macrophage progenitors and MEPs (24). It has
recently been claimed that the canonical CMP population is
internally heterogeneous with respect to lineage potential (14).
According to this research, the expression level of the cytokine
receptor flk2 is a marker for functional divergence: the flk2
CMP compartment is PU.1hi, has lost MEP potential, and retains
lymphoid as well as myeloid potential; f lk2 CMPs comprise
mostly PU.1lo cells with predominantly MEP potential. Our
measurements reveal a sharp divergence in PU.1 expression
within the flk2 and flk2CMP subsets. TheGAPDH results for
these subsets, discussed below, add further evidence that they are
nontrivially distinct, as the two-dimensional gene-expression
plot in Fig. 4 makes clear. The similarity between PU.1 expres-
sion in the CMPf lk2 cells and the MEPs meshes with the
observation that the bulk of the flk2 CMP compartment is
already megakaryocyte-erythroid-lineage restricted.
The expression of GAPDHwas not constant across the six cell
types examined, with the subset mean expression levels varying
over a 2-fold range (Table 5, which is published as supporting
information on the PNAS web site). K-S tests show that the
differences are statistically significant (Table 6, which is pub-
lished as supporting information on the PNAS web site). In 4 of
10 pairwise comparisons between subsets, the hypothesis that the
data came from the same underlying distribution had a P value
below 0.05. The CMPf lk2 subset had the highest GAPDH
expression, and it was also the best resolved from the other
subsets by the K-S measure.
The variation in GAPDH level within these closely related
subsets highlights a problem with the use of endogenous controls
in RT-PCR quantitation. Normalization to the GAPDH signal
reduces the apparent magnitude of PU.1 up-regulation in the
CMPf lk2 cell type, and equalizes the differences in mean
expression between the HSC, CLP and CMPf lk2 types (Table
1). It is impossible to say, at this level of analysis, whether such
Fig. 3. Gene expression in cDNA copies per cell, by cell type. The histograms
show the number of individual cells in each subset that expressed PU.1 and
GAPDH within the indicated bin ranges. PU.1 expression is heterogeneous in
the stem cells, up-regulated in the CMPflk2 cells, down-regulated in CMP
flk2 cells, and sharply down-regulated in the MEPs. The similarity between
PU.1 expression in CMPflk2 and MEP cells is consistent with the possibility
that flk2 CMPs are already biased toward the MEP lineage choice. GAPDH
expression was significantly elevated in the CMPflk2 cells, adding weight to
the inference that the flk2 and flk2 CMP subpopulations are functionally
distinct.
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equalization is justified. Although normalized measurements are
not necessarily less informative than absolute measurements, no
two housekeeping genes can reasonably be expected to show the
same dependence on cell type. No consensus exists as to the best
choice of endogenous control and, indeed, no one gene is likely
to be a good reference for every application (25). Weighted
normalization schemes based on multiple housekeeping genes
have been proposed (26). Still, it can be argued that this only
makes the problem of standardization worse. The uncertainty
which the practice of normalization introduces into gene mea-
surement comparisons can only be resolved by a move to
absolute quantitation, either through the use of quantitated
synthetic controls (e.g., purified PCR product or RNA runoff
transcript), or by the adoption of techniques which yield absolute
measurements directly, such as the one described here.
It has recently been reported that the abundance of gene
transcripts is lognormally distributed at the single-cell level (27).
We used several standard normality tests to ask whether the
expression of GAPDH within each population was compatible
with a normal or lognormal distribution (Table 7, which is
published as supporting information on the PNAS web site). In
all but the CMPf lk2 population, the lognormal model was
clearly preferred. Lognormal distributions can arise when nor-
mally distributed variations compound multiplicatively, as might
occur during the sequential steps of biochemical synthesis (28).
Intermittent, exponentially distributed bursts of biosynthesis can
also give rise to similar, nonnormal, positively skewed distribu-
tions (29) which are also consistent with our observations. The
geometric standard deviations for the GAPDH data sets are in
the range of 1.8–3.1 (Table 5), which indicates that transcript
levels can routinely fluctuate over a full one-log range. It might
seem surprising that robust behavior can be achieved by a system
in which signal levels vary so widely. It must be remembered,
however, that a snapshot of mRNA transcript level is not
necessarily a true measure of the abundance of the correspond-
ing protein. Messenger transcripts generally turn over much
faster than the proteins they encode, which implies that protein
expression may be buffered against stochastic f luctuations at the
mRNA level.
Redundancy and distributed control are additional strategies
by which cells could make up for the inherent sloppiness of
biochemical signaling (30). If so, efforts to ‘‘reverse-engineer’’
the transcriptional circuits controlling development must ulti-
mately address the synthesis of quantitative observations on
multiple transcription factors within single cells. The power of
flow cytometric population analysis has increased as the tech-
nology for multiplexing has improved; we expect the same to be
true of single-cell surveys conducted at the transcriptional
network level. In hematopoiesis, cell fate decisions depend on
the coordinate activity of multiple transcription factors (31).
When the targets for quantification are present at of the order
of ten copies, a subdivision of the sample to permit independent
single-plex assays introduces substantial measurement noise. For
several reasons, digital PCR offers improved scope for high-
order multiplexing relative to conventional quantitative PCR. In
a standard multiplex PCR, mismatched transcript levels can lead
to competitive inhibition of reactions involving less abundant
targets, which is typically addressed by adjusting primer concen-
trations so that the amplification of abundant targets is primer-
limited. Such fine-tuning may not be practical in single-cell
surveys, if transcript levels vary widely on a cell-by-cell basis, and
is obviated in the digital assay. A second benefit arises from the
concentration of template molecules because of reaction parti-
tioning, which ameliorates the impact of primer–dimer side
reactions. On the readout side, the digital assay lends itself to
bar-coding schemes, whereby distinct probe color combinations
are assigned to each target (32).
Conclusion
If cross-sectional analysis of cell populations at the transcriptional
network level were to become routine, the impact on developmen-
tal studies could be profound. In the near term, PCR-based
methods cannot be expected to yield single-cell expression datawith
the speed and economy of flow cytometry. This must be set against
the consideration that transcription factor studies provide data
bearing directly on the internal decision-making machinery of the
cell. In a small-scale survey we could easily resolve two subpopu-
Table 1. Gene expression by subset
Cell type
No. of
samples
Mean PU.1
cDNAs per cell
Mean GAPDH
cDNAs per cell
PU.1:GAPDH
ratio
HSC 21 8.5 58 0.15
CLP 23 5.5 37 0.15
CMPflk2 25 21.7 72 0.30
CMPflk2 24 6.5 47 0.14
MEP 23 3.7 61 0.06
Fig. 4. Resolution of flk2 and flk2 CMP populations based on gene
expression. (a) The sort gates used to fractionate CMP cells into flk2 and flk2
subsets (biexponential plot). These gates were applied after first selecting
Lineage c-kit ScaIlo IL7R CD34 FcGrlo cells. (b) The distribution of GAPDH
and PU.1 expression in the flk2 and flk2 CMP subsets, as determined by
single-cell analysis. The shaded ellipsoids capture 85% of the observations
within each set.
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lations within a progenitor type, the CMP, which has until recently
been considered homogeneous. Here we were able to focus the
analysis based on recent findings from the hematopoiesis literature.
In principle, however, the heterogeneity in PU.1 levels within the
CMP compartment could have been detected in a ‘‘blind’’ single-
cell survey. The scale of survey required to detect network state
diversity will depend on several factors, including (i) the relative
frequencies of divergent subsets, (ii) the magnitude and sharpness
of the expression differences, and (iii) the extent to which such
differences are correlated across transcripts and surface markers
analyzed in the survey. If the case of PU.1 expression in the CMP
is representative, indications of heterogeneity should emerge after
looking at a few tens of cells, and surveys at the 100- to 1,000-cell
level may offer significant insight into population substructure.
We have shown that it is possible to extend the sensitivity of
quantitative RT-PCR to permit profiling of transcription factor
expression within individual cells. This opens the door to sophis-
ticated regulatory network analysis on even the rarest developmen-
tal progenitors. The dynamic range of the chip assay is suited to
measuring the gamut of expression levels for regulatory genes,
whether working from single-cell samples or from higher numbers
of cells prepared at appropriately scaled concentration. By com-
bining flow cytometry and digital RT-PCR, we can put gene
expression measurements on an absolute, copy-number-per-cell
basis. The attainment of this ‘‘gold standard’’ should facilitate the
spread of public databases cataloguing cell-type-specific expression
data. Our assay can also support the progressive refinement of the
taxonomies underlying such resources through the single-cell survey
approach, helping to uncover diversity at the level of the cell’s most
delicate apparatus, the transcriptional regulatory network.
Materials and Methods
Microfluidic Digital PCR Chip.The single-cellmeasurements reported
here were made using the Digital Array chip (Fluidigm, South San
Francisco, CA). This single-use device supports the simultaneous
analysis of 12 samples. Within each sample panel, fluid is distrib-
uted into parallel, dead-end channels under pneumatic pressure.
After the load step, a comb valve with teeth at right angles to these
channels is actuated, deflecting an elastomeric membrane down to
partition the panel into 1,200 isolated reaction chambers. The chip
is then thermocycled, carrying out a total of 14,400 PCRs at once.
A microarray scanner is used to image the chip at the end point of
PCR. If a panel holds1,200 copies of template at the start of the
PCR, the copy number can be read out accurately just by counting
positive reactions. At higherDNA titers, a significant fraction of the
reaction chambers capture more than one copy of template, and
there is no longer a simple correspondence between positive
reactions and individual template molecules. However, unless a
panel is at or near saturation, template abundance can still be
calculated with acceptable precision (Supporting Text, which is
published as supporting information on the PNAS web site). The
quantitative dynamic range of the Digital Array is therefore about
three logs: from a single copy to on the order of a thousand copies.
This should be sufficient for single-cell quantification of all but the
most abundant mRNA species (33).
Synthetic Standards. PU.1 and GAPDH RNA runoff transcripts
were made for use in evaluating the RT efficiency and PCR
amplification efficiency of our assays. The transcripts were
designed to flank the amplicon regions of the TaqMan assays by
at least 100 bases on each side, so that the secondary structure
context seen by the reverse transcriptase would be similar to that
in lysate-based reactions. PCR products incorporating a T7RNA
polymerase promoter were used as template for the runoff
reactions, which were done with the MEGAscript T7 kit (Am-
bion, Austin, TX). The concentration of the purified RNA was
measured by UV absorbance spectroscopy, and the percentage
of full-length template was estimated with a capillary electro-
phoresis system (Experion; Bio-Rad, Hercules, CA).
The PCRs used to make templates for runoff transcription were
based on Mouse GAPDH DECAtemplate and Mouse Thymus
PCR-Ready cDNA (Ambion). The PCR primers were as follows
(T7 promoter tails underlined): for PU.1, 5-TAATACGACT-
CACTATAGGGAGACTGACCCACGACCGTCCAGT-3 (for-
ward) and 5-TTGTCCTTGTCCACCCACCA-3 (reverse); for
GAPDH, 5-TAATACGACTCACTATAGGGAGCCCAT-
CACCATCTTCC-3 (forward) and 5-CTGTAGCCGTAT-
TCATTGTC-3 (reverse).
TaqMan Assay Design. All RT-PCR data reported here were
obtained by using duplex PU.1GAPDH TaqMan assays. Prim-
ers and probes were designed with commercial software (Beacon
Designer; Premier Biosoft, Palo Alto, CA), accepting the default
Tm criteria for TaqMan assay design, which are based on a
standard 60°C annealingextension step during the PCR. Prim-
ers were chosen so that the amplicon range was free of predicted
secondary structure, as this is thought to impede efficient reverse
transcription. To minimize background signal from genomic
template, the PU.1 assay was designed so that the forward primer
straddled an exon splice site. Assays were validated empirically
using conventional quantitative PCR standard curve analysis
with runoff transcript as template. Primers were at 100 nM
concentration and probes at 50 nM concentration in all of the
reported experiments. Oligonucleotides were synthesized by
Integrated DNA Technologies (Coralville, IA).
The oligonucleotides used in the TaqMan assays were
as follows: for PU.1, 5-CATAGCGATCACTACTGGGA-
TTTC-3 (forward primer), 5-GGTTCTCAGGGAAGTTCT-
CAAA-3 (reverseRT primer), and 5-CGCACACCATGTC-
CACAACAACGA-3 (Cy5-labeled probe); for GAPDH, 5-
CCAATGTGTCCGTCGTGGATC-3 (forward primer), 5-
GCTTCACCACCTTCTTGATGTC-3 (reverseRT primer),
and 5-CGTGCCGCCTGGAGAAACCTGCC-3 (FAM-
labeled probe).
RT Efficiency Measurements. For on-chip standard curve assays,
equimolar mixtures of PU.1 and GAPDH runoff transcript were
added to RT-PCR buffer and the same digital RT-PCR protocol
used on the cell lysates (described below) was executed on the
samples. Three identical on-chip standard curve experiments were
run, with each chip bearing four sets of three samples, at nominal
template concentrations of 12.5, 25, 50, and 100 copies per micro-
liter. All samples were derived from the same master mix; each
individual sample was reverse-transcribed in a separate tube. Data
were recovered from 35 of the 36 panels in these chips.
Cell Isolation and Staining. A bone marrow cell suspension was
prepared from five 8- to 12-week-old C57BL6 mice. The suspen-
sion was filtered through a nylonmembrane and contaminating red
cells were lysed with ACK. The isolate was enriched for c-kit-
positive early progenitor cells by immunomagnetic separation with
anti-c-kit MACS beads (Miltenyi Biotec Auburn, CA). The cells
were next stained for other surface markers by using the following
fluorescent antibodies: CD34 FITC, flk2 phycoerythrin, Lineage
phycoerythrin-Cy5 (a mixture of antibodies including CD3, CD4,
CD5, CD8, B220, Mac1, Gr1, and Ter119), Sca-1 Cy5.5-
phycoerythrin, FcGr allophycocyanin, c-kit allophycocyanin-Cy7,
and IL7Ra biotin. All antibodies were from Ebiosciences (San
Diego, CA), except CD34 FITC (Pharmingen, SanDiego, CA) and
IL7Ra biotin (I.L.W.’s laboratory). The cells were then stainedwith
streptavidin QD605 (Quantum Dot, Hayward, CA) to tag the
IL7Ra antibodies and resuspended in PBS plus 2% FCS, with
propidium iodide added to mark apoptotic cells.
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Cell Sorting and Lysis. Cells were sorted to 0.2-ml sample tubes in
12-tube strips by using the FACSAria cell sorter (BD Bio-
sciences, San Jose, CA). Doublets and dead or apoptotic cells
were excluded based on forward scatterside scatter and pro-
pidium iodide staining. All cells were sorted using Lineage and
c-kit gates; additional sort criteria used to fractionate the cells
into specific progenitor subsets were as indicated in Fig. 5.
Individual cells were dispensed into 10-l aliquots of RT-PCR
buffer. The buffer components included a commercial RT-PCR
mix (Platinum One-Step Reaction Buffer; Invitrogen, Carlsbad,
CA), an RNase inhibitor (Ambion SUPERase-In), and 0.15%
Tween 20 detergent. The latter was included as a surfactant to
prevent nucleic acids binding the PDMS walls of the Digital
Array during the PCR assay. No special cell lysis reagents were
added. In tests, the efficiency and reproducibility of cDNA
recovery was at least as good using direct hypotonicdetergent
lysis in the RT-PCR buffer as obtained using chaotropic lysis
with subsequent RNA purification.
Reverse Transcription. Reverse transcription reactions were done at
55°C for 15 min, and followed by a 5-min, 70°C step to heat-
denature the reverse transcriptase. Completed reactions were
stored at20°C for later PCRanalysis. TheRT stepwas carried out
in a 96-well block thermocycler. Three microliters of 5	 primer–
probe mix was added to each frozen lysate, after which the samples
were spun down and transferred to the preheated thermocycler
block. As a precaution to minimize primer–dimer extension by the
reverse transcriptase, the samples were warmed to 55°C before
adding 2-l aliquots of enzyme to the reactions. MMLV RTTaq
polymerase enzyme blend (CellsDirect SuperScript IIIPlatinum
Taq; Invitrogen) was diluted in RT-PCR buffer to stabilize the
enzyme; the final reaction concentration was as directed by the
manufacturer.
cDNA Quantitation. Digital Array chips mounted on 75 	 50-mm
glass slides were primed for use by filling the control layer with
osmolyte (35% PEG 3,350). For each assay, 12 stored reverse
transcription reactions were thawed, drawn into gel tips, and
loaded into a chip under 15-psi pneumatic pressure. The load was
performed in a cold room at 4°C and took30 min. The sample
load step was controlled manually with a 12-port manifold fed
from a house air supply and connected to the gel tips by Tygon
tubing with custom-made hose adaptors. After the load, the chip
was transferred to a flat-block thermocycler; paraffin oil was
used to improve thermal contact between the block and the
glass-slide base. Samples were partitioned by applying 27.5-psi
pneumatic pressure to the control layer comb valve via a gel tip
filled with osmolyte solution. The PCR profile included a 3-min,
95°C hot-start to activate the Taq, followed by 40 cycles of a
two-step program: 15 seconds at 95°C (denaturation) and 60
seconds at 60°C (annealing and extension). After PCR, chips
were imaged with an ArrayWoRx microarray scanner (Applied
Precision, Issaquah,WA), adapted to accept a chip carrier. Scans
were done at 13-m resolution by using FAM and Cy5 filter sets.
We wrote our own software to process the PCR end-point images
and compute the template concentrations in each panel. The
loaded sample volume in the chip, 7.5 l (manufacturer’s data),
represents half the volume of the reverse-transcribed lysate. All
of the single-cell cDNA copy number data reported here was
derived by multiplying the calculated template concentration in
copies per microliter by the total lysate reaction volume, 15 l.
Data Analysis.Normality tests were donewithXLSTAT (Addinsoft,
New York, NY). The test input consisted of the reported cDNA
copy number for each cell in the set (normal test), or the log of the
copy number (lognormal test). We wrote software to perform
expression data set comparisons based on the K-S routines given in
ref. 34. When used to compare two data sets, the algorithm
calculates the maximum absolute distance between their respective
cumulative distributions, and computes from this measure the
significance of the null hypothesis that both data sets came from the
same underlying distribution. The analysis does not involve any
assumptions about the character of the underlying distributions
involved.
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